Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R C Bentley

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Gynecologic Oncology|September 10, 1999
Epidemiologic and surgicopathologic findings of papillary serous and clear cell endometrial cancers when compared to endometrioid carcinomaF D Cirisano, S J Robboy, R K Dodge, et al.
Cancer Research|March 1, 1995
Malignant transformation of the human endometrium is associated with overexpression of lactoferrin messenger RNA and proteinD K Walmer, C J Padin, M A Wrona, et al.
Archives of Pathology & Laboratory Medicine|May 1, 1997
Malignant supratentorial glial-neuronal neoplasms: report of two cases and review of the literatureR E McLendon, R C Bentley, J E Parisi, et al.
Oncogene|October 7, 2008
Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cellsT Baba, P A Convery, N Matsumura, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2001
Comparison of methods of measuring HER-2 in metastatic breast cancer patients treated with high-dose chemotherapyL N Harris, V Liotcheva, G Broadwater, et al.
British Journal of Cancer|February 16, 2012
Carbonic anhydrase IX is a predictive marker of doxorubicin resistance in early-stage breast cancer independent of HER2 and TOP2A amplificationA S Betof, Z N Rabbani, M E Hardee, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 31, 2020
Prognostic gene expression signature for high-grade serous ovarian cancerJ Millstein, T Budden, E L Goode, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Gynecologic Oncology|September 10, 1999
Epidemiologic and surgicopathologic findings of papillary serous and clear cell endometrial cancers when compared to endometrioid carcinomaF D Cirisano, S J Robboy, R K Dodge, et al.
Cancer Research|March 1, 1995
Malignant transformation of the human endometrium is associated with overexpression of lactoferrin messenger RNA and proteinD K Walmer, C J Padin, M A Wrona, et al.
Archives of Pathology & Laboratory Medicine|May 1, 1997
Malignant supratentorial glial-neuronal neoplasms: report of two cases and review of the literatureR E McLendon, R C Bentley, J E Parisi, et al.
Oncogene|October 7, 2008
Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cellsT Baba, P A Convery, N Matsumura, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2001
Comparison of methods of measuring HER-2 in metastatic breast cancer patients treated with high-dose chemotherapyL N Harris, V Liotcheva, G Broadwater, et al.
British Journal of Cancer|February 16, 2012
Carbonic anhydrase IX is a predictive marker of doxorubicin resistance in early-stage breast cancer independent of HER2 and TOP2A amplificationA S Betof, Z N Rabbani, M E Hardee, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 31, 2020
Prognostic gene expression signature for high-grade serous ovarian cancerJ Millstein, T Budden, E L Goode, et al.
Pageof 6